142 related articles for article (PubMed ID: 34564949)
1. Diagnostic implications of MicroRNAs; 155, 146 a, and 203 lesional expression in alopecia areata: A preliminary case-controlled study.
Mustafa AI; Al-Refaie AM; El-Shimi OS; Fawzy E; Sorour NE
J Cosmet Dermatol; 2022 Jun; 21(6):2648-2654. PubMed ID: 34564949
[TBL] [Abstract][Full Text] [Related]
2. Identification of blood microRNA alterations in patients with severe active alopecia areata.
Sheng Y; Qi S; Hu R; Zhao J; Rui W; Miao Y; Ma J; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14421-14430. PubMed ID: 30983035
[TBL] [Abstract][Full Text] [Related]
3. Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata.
Elmaadawy E; Elgarhy LH; Shareef M
J Cosmet Dermatol; 2019 Apr; 18(2):659-664. PubMed ID: 30556317
[TBL] [Abstract][Full Text] [Related]
4. Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis.
Maher SA; Ismail NA; Toraih EA; Habib AH; Gouda NS; Gomaa AHA; Fawzy MS; Helal GM
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625530
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of TLR7 and TLR9 in alopecia areata.
Kang H; Wu WY; Yu M; Shapiro J; McElwee KJ
Exp Dermatol; 2020 Mar; 29(3):254-258. PubMed ID: 31571275
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory Vδ1
Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R
J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243
[TBL] [Abstract][Full Text] [Related]
7. Expression of Long Noncoding RNA, HOTAIR, and MicroRNA-205 and Their Relation to Transforming Growth Factor β
Mohamad N; Khedr AMB; Shaker OG; Hassan M
Skin Appendage Disord; 2023 Mar; 9(2):111-120. PubMed ID: 36937162
[TBL] [Abstract][Full Text] [Related]
8. Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata.
Ye Y; Zhao Y; Gong Y; Zhang X; Caulloo S; Zhang B; Cai Z; Yang J; McElwee KJ; Zhang X
Lupus; 2013 Dec; 22(14):1439-45. PubMed ID: 24132518
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and p53 genes in patients with alopecia areata: A case-control study.
Marie REM; Abd El-Fadeal NM; Atef LM
Australas J Dermatol; 2021 Feb; 62(1):e29-e34. PubMed ID: 32951213
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment.
Fuentes-Duculan J; Gulati N; Bonifacio KM; Kunjravia N; Zheng X; Suárez-Fariñas M; Shemer A; Guttman-Yassky E; Krueger JG
Exp Dermatol; 2016 Apr; 25(4):282-6. PubMed ID: 26661294
[TBL] [Abstract][Full Text] [Related]
12. Serum granulysin as a possible key marker of the activity of alopecia areata.
Ono S; Otsuka A; Yamamoto Y; Kataoka TR; Koyanagi I; Miyachi Y; Kabashima K
J Dermatol Sci; 2014 Jan; 73(1):74-9. PubMed ID: 24035442
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy.
Petukhova L; Patel AV; Rigo RK; Bian L; Verbitsky M; Sanna-Cherchi S; Erjavec SO; Abdelaziz AR; Cerise JE; Jabbari A; Christiano AM
Exp Dermatol; 2020 Mar; 29(3):243-253. PubMed ID: 31169925
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.
Salem SA; Asaad MK; Elsayed SB; Sehsah HM
Int J Dermatol; 2016 Dec; 55(12):1357-1361. PubMed ID: 27420731
[TBL] [Abstract][Full Text] [Related]
15. An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata.
Glickman JW; Dubin C; Dahabreh D; Han J; Del Duca E; Estrada YD; Zhang N; Kimmel GW; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
Allergy; 2021 Oct; 76(10):3053-3065. PubMed ID: 33721346
[TBL] [Abstract][Full Text] [Related]
16. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity.
Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S
Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
18. CHAC1 as a novel biomarker for distinguishing alopecia from other dermatological diseases and determining its severity.
Karami H; Nomiri S; Ghasemigol M; Mehrvarzian N; Derakhshani A; Fereidouni M; Mirimoghaddam M; Safarpour H
IET Syst Biol; 2022 Sep; 16(5):173-185. PubMed ID: 35983595
[TBL] [Abstract][Full Text] [Related]
19. Differential expression patterns of specific long noncoding RNAs and competing endogenous RNA network in alopecia areata.
Sheng Y; Ma J; Zhao J; Qi S; Hu R; Yang Q
J Cell Biochem; 2019 Jun; 120(6):10737-10747. PubMed ID: 30790320
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata.
AbdElneam AI; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
Skin Res Technol; 2024 Mar; 30(3):e13657. PubMed ID: 38528743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
